136 related articles for article (PubMed ID: 37237443)
1. Diagnostic and management roles of FDG PET/CT imaging in post-transplant lympho-proliferation in pediatric heart transplantation.
Brown AK; Carapellucci J; Oshrine B; Gomez A; Meoded A; Asante-Korang A
Clin Transplant; 2023 Sep; 37(9):e15015. PubMed ID: 37237443
[TBL] [Abstract][Full Text] [Related]
2. The value of 18F-FDG PET in pediatric patients with post-transplant lymphoproliferative disorder at initial diagnosis.
Vali R; Punnett A; Bajno L; Moineddin R; Shammas A
Pediatr Transplant; 2015 Dec; 19(8):932-9. PubMed ID: 26515450
[TBL] [Abstract][Full Text] [Related]
3.
Montes de Jesus FM; Glaudemans AWJM; Tissing WJ; Dierckx RAJO; Rosati S; Diepstra A; Noordzij W; Kwee TC
J Nucl Med; 2020 Sep; 61(9):1307-1313. PubMed ID: 32005775
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic performance of FDG-PET/CT of post-transplant lymphoproliferative disorder and factors affecting diagnostic yield.
Montes de Jesus FM; Kwee TC; Kahle XU; Nijland M; van Meerten T; Huls G; Dierckx RAJO; Rosati S; Diepstra A; van der Bij W; Verschuuren EAM; Glaudemans AWJM; Noordzij W
Eur J Nucl Med Mol Imaging; 2020 Mar; 47(3):529-536. PubMed ID: 31444510
[TBL] [Abstract][Full Text] [Related]
5. (18)F-FDG PET/CT in the management of patients with post-transplant lymphoproliferative disorder.
Takehana CS; Twist CJ; Mosci C; Quon A; Mittra E; Iagaru A
Nucl Med Commun; 2014 Mar; 35(3):276-81. PubMed ID: 24296883
[TBL] [Abstract][Full Text] [Related]
6. Multicenter study of pediatric Epstein-Barr virus-negative monomorphic post solid organ transplant lymphoproliferative disorders.
Afify ZAM; Taj MM; Orjuela-Grimm M; Srivatsa K; Miller TP; Edington HJ; Dalal M; Robles J; Ford JB; Ehrhardt MJ; Ureda TJ; Rubinstein JD; McCormack S; Rivers JM; Chisholm KM; Kavanaugh MK; Bukowinski AJ; Friehling ED; Ford MC; Reddy SN; Marks LJ; Smith CM; Mason CC
Cancer; 2023 Mar; 129(5):780-789. PubMed ID: 36571557
[TBL] [Abstract][Full Text] [Related]
7. Preliminary experience on the use of PET/CT in the management of pediatric post-transplant lymphoproliferative disorder.
Guerra-García P; Hirsch S; Levine DS; Taj MM
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28612477
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients.
Schubert S; Abdul-Khaliq H; Lehmkuhl HB; Yegitbasi M; Reinke P; Kebelmann-Betzig C; Hauptmann K; Gross-Wieltsch U; Hetzer R; Berger F
Pediatr Transplant; 2009 Feb; 13(1):54-62. PubMed ID: 18518912
[TBL] [Abstract][Full Text] [Related]
9. Hodgkin lymphoma post-transplant lymphoproliferative disorder following pediatric renal transplant: serial imaging with F-18 FDG PET/CT.
Makis W; Lisbona R; Derbekyan V
Clin Nucl Med; 2010 Sep; 35(9):704-5. PubMed ID: 20706047
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr DNA serology and positron-emission tomography imaging of the head and neck in pediatric transplant recipients.
Sidell D; Venick RS; Shapiro NL
Laryngoscope; 2014 May; 124(5):1236-41. PubMed ID: 24105893
[TBL] [Abstract][Full Text] [Related]
11. The value of
Si Z; Lu D; Zhai L; Zheng W; Dong C; Sun C; Wang K; Zhang W; Wei X; Zhang Z; Zhao S; Gao W; Shen Z
Pediatr Transplant; 2023 Aug; 27(5):e14501. PubMed ID: 36906739
[TBL] [Abstract][Full Text] [Related]
12.
Chen J; Zhang X; Ma L; Gao Y; Fu Z; Liu M
Front Med (Lausanne); 2023; 10():1258310. PubMed ID: 37663666
[TBL] [Abstract][Full Text] [Related]
13. Detection of bone marrow involvement in newly diagnosed post-transplant lymphoproliferative disorder: (18)F-fluorodeoxyglucose positron emission tomography/computed tomography versus bone marrow biopsy.
Gheysens O; Thielemans S; Morscio J; Boeckx N; Goffin KE; Deroose CM; Sagaert X; Wlodarska I; Verhoef G; Dierickx D; Tousseyn T
Leuk Lymphoma; 2016 Oct; 57(10):2382-8. PubMed ID: 26854937
[TBL] [Abstract][Full Text] [Related]
14. False-Positive [18F]fluorodeoxyglucose-avid lymph nodes on positron emission tomography-computed tomography after allogeneic but not autologous stem-cell transplantation in patients with lymphoma.
Ulaner GA; Lilienstein J; Gönen M; Maragulia J; Moskowitz CH; Zelenetz AD
J Clin Oncol; 2014 Jan; 32(1):51-6. PubMed ID: 24248697
[TBL] [Abstract][Full Text] [Related]
15. Clinical usefulness of FDG-PET/CT scan imaging in the management of posttransplant lymphoproliferative disease.
Bianchi E; Pascual M; Nicod M; Delaloye AB; Duchosal MA
Transplantation; 2008 Mar; 85(5):707-12. PubMed ID: 18337664
[TBL] [Abstract][Full Text] [Related]
16. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
Schubert S; Renner C; Hammer M; Abdul-Khaliq H; Lehmkuhl HB; Berger F; Hetzer R; Reinke P
J Heart Lung Transplant; 2008 Jan; 27(1):100-5. PubMed ID: 18187094
[TBL] [Abstract][Full Text] [Related]
17. Semi-Quantitative Characterization of Post-Transplant Lymphoproliferative Disorder Morphological Subtypes with [
Montes de Jesus F; Vergote V; Noordzij W; Dierickx D; Dierckx RAJO; Diepstra A; Tousseyn T; Gheysens O; Kwee TC; Deroose CM; Glaudemans AWJM
J Clin Med; 2021 Jan; 10(2):. PubMed ID: 33477971
[No Abstract] [Full Text] [Related]
18. The role of 18F-FDG PET/CT in the evaluation of pediatric transplant patients.
Yang J; Zhuang H
Hell J Nucl Med; 2015; 18(2):136-9. PubMed ID: 26187213
[TBL] [Abstract][Full Text] [Related]
19. Posttransplant lymphoproliferative disorder in pediatric renal transplantation.
Srivastava T; Zwick DL; Rothberg PG; Warady BA
Pediatr Nephrol; 1999 Nov; 13(9):748-54. PubMed ID: 10603113
[TBL] [Abstract][Full Text] [Related]
20. Post-transplantation lymphoproliferative disease in pediatric liver recipients in Taiwan.
Hsu CT; Chang MH; Ho MC; Chang HH; Lu MY; Jou ST; Ni YH; Chen HL; Hsu HY; Wu JF
J Formos Med Assoc; 2019 Nov; 118(11):1537-1545. PubMed ID: 30630698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]